Updated 2026-08-21 · NCT06897475See eligibility →
City
Clinical trials near Birmingham, United Kingdom
Active studies with a listed research site in Birmingham, United Kingdom.
14active studies
6recruiting now
21countries represented
60largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-08-21 · NCT06309238See eligibility →
Recruiting nowNot applicable
Effects of Obesity on Autophagy and mTORC1 Signalling in Skeletal Muscle
Updated 2026-08-19 · NCT07774676See eligibility →
Recruiting nowNot applicable
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Updated 2026-05-04 · NCT07443956See eligibility →
Updated 2026-02-12 · NCT06760546See eligibility →
Recruiting nowNot applicable
The European NAFLD Registry
Updated 2023-01-06 · NCT04442334See eligibility →
Invitation onlyPhase 2
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
Updated 2026-02-10 · NCT07156578See eligibility →
Active, not recruitingNot applicable
Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity
Updated 2026-08-24 · NCT06321458See eligibility →
Active, not recruitingPhase 3
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Updated 2026-08-10 · NCT05774756See eligibility →
Active, not recruitingPhase 3
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
Updated 2026-08-07 · NCT05726227See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
Updated 2026-04-17 · NCT07232719See eligibility →
Active, not recruitingPhase 3
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
Updated 2026-03-03 · NCT06859268See eligibility →
Active, not recruitingNot applicable
Intensive Weight Loss Intervention Versus Usual Care for Adults With Obesity
Updated 2026-02-10 · NCT06321432See eligibility →
Active, not recruitingNot applicable
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
Updated 2025-07-28 · NCT05221229See eligibility →
Related cities
Beijing, China123Boston, United States76Houston, United States75Shanghai, China74Chicago, United States70New York, United States59
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.